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Activation of Gs protein increases the intracellular cyclic adenosine monophosphate (cAMP) level, and the Gs
protein-linked receptor has been implicated in the skin barrier homeostasis. In this study, we investigated the role
of cAMP in epidermal barrier function. The barrier was disrupted by tape stripping or treatment with acetone.
Immediately after barrier disruption, reagents affecting the cAMP level were topically applied. Topical application of
forskolin, which activates cAMP synthesis delayed barrier recovery, whereas application of the antagonist of cAMP,
cAMP-Rp, accelerated barrier recovery. Moreover, application of 9-cyclopentyladenine, an inhibitor of cAMP
synthesis also accelerated barrier recovery. Tape stripping was found to increase the cAMP in the epidermis. Light
and electron microscopic observations showed the delay of lamellar body secretion by forskolin and acceleration
of the lamellar body secretion by cAMP-Rp. Application of an inhibitor of protein kinase A did not affect the barrier
recovery rate. The delay of barrier recovery induced by forskolin was blocked by the voltage-gated calcium channel
blockers, nifedipine and verapamil. In cultured keratinocytes, forskolin increased the intracellular calcium
concentration and both nifedipine and verapamil blocked the increase. These results suggest that intracellular
cAMP in the epidermis is involved in skin barrier homeostasis.
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The stratum corneum (SC) forms a water impermeable
barrier in the uppermost layer of the epidermis. When it is
damaged by tape stripping, or treatment with an organic
solvent or detergent, it is spontaneously repaired in healthy
skin; however, the recovery is delayed with aging (Ghadially
et al, 1995) or psychologic stress (Denda et al, 2000).
Moreover, when the damage is repeated or when it occurs
under low environmental humidity, obvious epidermal
hyperplasia or inflammation is induced even by a small
level of barrier disruption (Denda et al, 1996, 1998a). Thus,
acceleration of barrier repair is clinically important.
The SC is composed of protein-rich nonviable cells and
intercellular lipid domains (Elias and Feingold, 2001). The
homeostatic system is activated when the barrier function is
damaged and the barrier function recovers its original level
(Elias and Feingold, 2001). At the first stage of barrier
recovery, exocytosis of lamellar bodies that are lipid-
containing granules, is accelerated and the inside lipids
are secreted into the intercellular domain between the
stratum granulosum (SG) and SC and forms a water
impermeable membrane. Menon et al (1994) reported that
calcium localization plays an important part in the secretion
of lamellar bodies, but the intracellular signaling system has
not been clarified. Several hours after the secretion of
lamellar bodies, the lipid synthesis starts in the epidermis
(Elias and Feingold, 2001).
Previously, we demonstrated the involvement of several
neurotransmitters in the barrier homeostasis. For example,
topical application of glutamate, N-methyl-D-aspartic acid,
and nicotine delayed the barrier recovery and application of
g-aminobutyric acid and glycine accelerated it (Denda et al,
2003a; Fuziwara et al, 2003). These reagents are ligands of
ionotropic receptors. We also found that calcium ion flux
into keratinocytes reduced the secretion of lamellar bodies
and delayed barrier recovery, whereas chloride ion influx
into the keratinocyte accelerated the secretion of lamellar
bodies and consequently barrier recovery (Denda et al,
2003a). These results suggest that the ion flux is crucial for
the first phase of the barrier recovery process.
On the other hand, we recently demonstrated that
application of adrenergic b2 receptor agonists delayed the
barrier recovery of skin permeability, whereas b2 receptor
antagonists accelerated it (Denda et al, 2003b). The
adrenergic b2 receptor is not an ionotropic receptor, but
the agonist of the receptor increased the intracellular
calcium level of keratinocytes. The voltage-gated calcium
channel blockers, nifedipine and verapamil, blocked the
increase of intracellular calcium and they also blocked
the delay of the barrier repair induced by the agonist of
b2 adrenergic receptor. Activation of the adrenergic b2
receptor increases cyclic adenosine monophosphate
(cAMP) via Gs protein, which in turn opens the voltage-
gated calcium channel in smooth muscle cells (Keef et al,
2001). From these observations, we hypothesized that the
increase of intracellular cAMP induces a calcium influx into
keratinocytes through the voltage-gated calcium channel
Abbreviations: TEWL, transepidermal water loss; SC,
stratum corneum; SG, stratum granulosum.
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and delays barrier recovery. cAMP is involved in a variety of
second signaling systems of Gs or Gi protein-linked
receptors. The signal activates the voltage-gated calcium
channel directly or via the activation of protein kinase A
(PKA). Receptors linked to the Gs/Gi protein have been
suggested to exist in the keratinocyte (Lundeberg et al,
2002; Denda et al, 2003b). If cAMP is involved in skin barrier
homeostasis, several receptors might be associated in
barrier homeostasis. In this study, we evaluated the effects
of reagents altering the cAMP level on the skin barrier
recovery and then we examined the level of cAMP after
barrier disruption. We also examined the effect of a PKA
inhibitor on barrier homeostasis. Finally, we verified the
relationship between cAMP and voltage-gated calcium
channel in the barrier function and calcium dynamics in
keratinocytes.
Results
To study the relationship between skin barrier homeostasis
and cAMP level in the epidermis, we first examined the
effects of topical application of reagents, which alter the
intracellular cAMP level, on barrier recovery after barrier
disruption. Figure 1 shows the effects of topical application
of 100 mL of 100 mM cAMPs Rp, an antagonist of cAMP, 100
mL of 100 mM 9-cyclopenyl adenine, inhibitor of cAMP
synthesis (inhibitor of adenyl cyclase), and 100 mL of 100 mM
forskolin, which increases the level of cAMP after tape
stripping (Fig 1A) and acetone treatment (Fig 1B). In both
cases, cAMPs Rp accelerated barrier recovery, whereas
forskolin delayed it 1, 3, and 6 h after barrier disruption.
Inhibition of cAMPs synthesis by 9-cyclopenyl adenine also
accelerated barrier recovery (Fig 1C). These results suggest
that barrier disruption increased cAMP synthesis and
delayed barrier recovery.
To ascertain the contribution of cAMP on the barrier
recovery, we next evaluated the level of cAMP in the
epidermis after tape striping. Figure 2 shows the level of
cAMP in the epidermis with or without tape stripping. Tape
stripping increased the level of cAMP 3-fold 1 h after the
tape stripping. These results suggest that the intracellular
cAMP level was increased immediately after barrier disrup-
tion and that blockage of the increase of cAMP accelerates
the barrier recovery. On the other hand, enhancement of
cAMP synthesis by forskolin delayed barrier recovery. The
barrier recovery rate depended on the intracellular cAMP
level. The difference of the barrier recovery rate between
each treatment appeared within 1 h after the treatment.
Alteration of cAMP level might affect the earlier stage of the
barrier recovery, i.e., secretion of lamellar bodies.
To clarify how cAMP delays barrier recovery, we next
observed lamellar body the secretion lamellar bodies and
intercellular lipids in the epidermis of each skin. One hour
after acetone treatment, Nile Red staining did not show any
obvious recovery of the lipid membrane (Fig 3D shows the
image of Fig 3A merged with the Nomarski image). The Nile
Red staining 1 h after 100 mM cAMPs Rp treatment showed
recovery of the intercellular lipid membrane in the upper
epidermis (Fig 3B, yellowish layers, indicated arrows, Fig 3E
shows the image of Fig 3B merged with the Nomarski
image), whereas no localization of lipid membrane was
observed in the skin treated with 100 mM forskolin (Fig 3C:
image of Fig 3C merged with the Nomarski image is shown
in Fig 3F).
An electron micrograph is shown in Fig 4. One hour after
acetone treatment, exocytosis of lamellar bodies was
observed in the SC/SG interface (Fig 4A, arrows). The SC/
SG lipid domain was smaller less many unsecreted lamellar
bodies were observed in the skin treated with 100 mM
forskolin (Fig 4B, arrowheads showed lamellar bodies). On
the other hand, a larger SC/SG lipid domain was observed
in the skin treated with cAMPs Rp (Fig 4C, asterisks).
Ruthenium staining showed a poor bilayer structure in the
SC/SG interface of the skin treated with forskolin (Fig 4D,
arrowhead shows unsecreted lamellar bodies), whereas a
partially more developed lamellar structure was observed in
the skin treated with cAMPs Rp (Fig 4E, asterisks). The
results of quantitation of the SC/SG intercellular lipid
domain are shown in Fig 5(F). The area of the SC/SG was
Figure 1
Topical application of the cAMP antagonist, cAMPs Rp, accelerated barrier recovery after tape stripping (A) and acetone treatment (B). On
the other hand, application of forskolin, which enhances cAMP synthesis delayed barrier recovery. Topical application of 9-cyclopentyladenine,
inhibitor of adenyl cyclase, accelerated barrier recovery after tape stripping (C). Two points were measured on one flank. The number of measured
points n¼ 8 (number of animals was 4 for each measurement).
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significantly thicker in the skin treated with cAMPs Rp than
those of the water-treated control and forskolin-treated
skin. This ultrastructural study suggested that the alteration
of cAMP in the epidermis affects the secretion of lamellar
bodies after barrier disruption.
In some cases, cAMP activates the voltage-gated
calcium channel by the activation of PKA (Kuno, 1995).
Thus, we evaluated the effect of a PKA inhibitor, KT5720 on
the barrier recovery. As shown in Fig 5, application of 100
mM KT5720 did not affect the barrier recovery rate. PKA was
not involved in the signaling process between barrier
homeostasis and cAMP level in the epidermis.
A previous study suggested that intracellular cAMP
affected the voltage-gated calcium channel in neurons
(Kuno, 1995). The voltage-gated calcium channel is involved
in skin barrier function (Denda et al, 2003b). To ascertain the
role of the voltage-gated calcium channel in the effect
of cAMP on barrier homeostasis, we examined the effect of
the voltage-gated calcium channel blocker on the delay of
barrier recovery induced by forskolin. The delay of barrier
recovery induced by 100 mM forskolin was blocked by
pretreatment with the voltage-gated calcium channel
blockers, 100 mM nifedipine and 100 mM verapamil (Fig 6).
Intracellular calcium of cultured keratinocytes increased
with 100 mM forskolin (Fig 7) and the increase was blocked
by 100 mM nifedipine and verapamil. These results suggest
that an increase of intracellular cAMP activated the voltage-
gated calcium channel and induced calcium influx into
epidermal keratinocytes. We recently demonstrated that the
calcium influx delayed the barrier recovery (Denda et al,
2003a). Thus, blockage of the voltage-gated calcium
channel might block the calcium influx and consequently
block the delay of the barrier recovery by forskolin.
Discussion
In this study, acceleration of the barrier was induced by the
inhibitor of cAMP synthesis and also by an antagonist of
cAMP. On the other hand, enhancement of cAMP synthesis
delayed barrier recovery. These phenomena were observed
in the early stage of recovery. Intracellular cAMP might play
an important part of the barrier recovery immediately after
barrier disruption.
Tape stripping increased the intracellular cAMP in the
epidermis. Previously, we suggested the increase of
endogenous ligands of adrenergic receptors after barrier
disruption (Denda et al, 2003b). The endogenous ligands
might induce the increase of intracellular cAMP via Gs
protein. The antagonist of cAMP accelerated barrier
recovery. This might be a result of the blockage of the
increase of endogenous cAMP.
Increased cAMP opens the voltage-gated calcium
channel of smooth muscle cells (Keef et al, 2001). The
relationship between the cAMP and intracellular calcium
level in keratinocytes, however, has not been clarified yet.
Figure 2
cAMP level was increased three times by tape stripping. Number of
animals: n¼ 9 (control); n¼ 8 (tape stripping). Results of ANOVA test:
F¼22,425, p¼ 0.0003.
Figure 3
The results of Nile Red staining 1 h
after acetone treatment and following
the application of cAMPs Rp and
forskolin are shown. Yellowish colored
layers show the recovery of lipid mem-
brane. One hundred microliters of 100
mM each reagent was applied immedi-
ately after acetone treatment. As a
control, 100 ml of water was applied. To
confirm the reproducibility, three animals
were used for each treatment. By acet-
one treatment, the lipid membranes in
the SC were completely removed with-
out recovery even 1 h after the treatment
together with the application of water
(A). (D) Shows an image of A merged
with the Nomarski image. Topical appli-
cation of cAMPs Rp accelerated the
recovery of the lipid membranes in the
upper epidermis (B, arrows, yellowish
colored layers). An image of (B) merged
with the Nomarski image is shown in (E).
On the other hand, obvious repair of
lipids membrane was not observed in
the skin treated with forskolin (C,
merged image with the Nomarski image
is shown in F). Bars¼ 10 mm.
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Several different cascades between cAMP and voltage-
gated calcium channel have been reported previously
(Kuno, 1995). For example, the voltage-gated channel is
also activated by the activation of PKA. In this study,
however, the antagonist of PKA did not affect the barrier
recovery process. cAMP might mediate the intracellular
calcium concentration through the voltage-gated calcium
channel directly in the epidermal keratinocytes.
The scheme of the process between Gs binding receptor
and voltage-gated calcium channel is shown in Fig 8. Skin
barrier disruption might activate a Gs protein-linked
receptor. It might activate adenyl cyclase and accelerate
synthesis of cAMP. Increased cAMP might open voltage-
gated calcium channel and induce calcium ion flux into
keratinocytes. PKA might not be involved in this cascade.
Influx of calcium ion delays the barrier recovery (Denda
et al, 2003a). Thus, inhibition of adenyl cyclase or antagonist
of cAMP might accelerate barrier recovery as we demon-
strated in this study.
In this study, barrier recovery was delayed by forskolin
and accelerated by cAMPs Rp or inhibitor of cAMP synthesis
within 1 h of the barrier disruption. Forskolin also caused an
immediate increase in the intracellular calcium concentra-
tion in the cultured keratinocytes. Thus, the influence of the
reagent in this study might be the result of the alteration of
the exocytosis of the lamellar body by calcium influx. The
light and electron microscopic observations supported this
speculation.
A variety of metabotropic Gs or Gi protein-linked
receptors potentially affect the intracellular cAMP level
(Kuno, 1995). Activation of Gs protein increases cAMP,
whereas activation of Gi protein decreases cAMP (Kuno,
1995). We previously demonstrated that the agonist of the
b2-adrenergic receptor delayed skin barrier recovery
(Denda et al, 2003b). The b2-adrenergic receptor is a Gs-
protein-linked receptor. Thus, activation of Gs protein
increases intracellular cAMP. On the other hand, antago-
nists of the b2 adrenergic receptor accelerated barrier
recovery (Denda et al, 2003b). The present findings are
consistent with the previous report.
Previous studies suggested that Gs/Gi-protein linked
receptors exist in the keratinocytes (Lundeberg et al, 2002;
Denda et al, 2003b). We previously demonstrated that
Figure 4
Electron microscopy revealed the influ-
ence of the level of cAMP on lamellar
body secretion into the SC/SG interface.
One hundred microliters of 100 mM of each
reagent was applied immediately after
acetone treatment. (A–C) Were stained with
osmium and (D,E) were stained with ruthe-
nium. One hour after acetone treatment,
exocytosis of the lamellar body was ob-
served in the SC/SG interface (A, arrows).
The SG/SC area was thin and unsecreted
lamellar bodies were observed in the skin
treated with forskolin (B, arrowhead: unse-
creted lamellar bodies). On the other hand,
a thick intercellular lipid domain was ob-
served in the skin treated with cAMPs Rp
(C, asterisks). (D) Showed the ruthenium-
stained section of skin treated with forsko-
lin. Arrowheads show the unsecreted lamel-
lar bodies. On the other hand, a thick lipid
bilayer structure was observed in skin
treated with cAMPs Rp (E, asterisks show
the lipid domain). The results of quantitation
are shown in (F). The result of ANOVA test is
shown at the top of the figure. Twelve
sections from three different animals were
used for each quantitation. Bars: (A–C) 2 mm;
(D,E) 200 nm.
Figure 5
Topical application of inhibitor of PKA did not affect the barrier
recovery rate after tape stripping. Two points were measured on skin
on one flank. Number of measured points, n¼ 8 (number of animals
was 4 for each measurement).
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psychologic stress influenced skin barrier homeostasis
(Denda et al, 2000). A variety of neurotransmitters such as
melatonin and serotonin might affect cutaneous barrier
homeostasis through various G protein-linked receptors.
Neural factors and epidermal homeostasis might be closely
linked through the receptors. Moreover, epidermal kerati-
nocytes have been suggested to synthesize melatonin or
serotonin (Slominski et al, 1994, 2002). These transmitters
might regulate epidermal homeostasis in an autocrine
manner.
This study showed that barrier disruption increased
cAMP. The increase is detrimental to barrier recovery. We
previously demonstrated that inflammatory responses
induced by barrier disruption could not be attributed to
the alteration of barrier function (Denda et al, 1996). The role
of increased cAMP is not clear. A previous study suggested
that cAMP was involved in cytokine expression (Becherel
et al, 1994). The increased cAMP might be associated with
the inflammatory responses of the skin.
In conclusion, cAMP in the epidermis is closely asso-
ciated with skin barrier homeostasis. Barrier disruption
increased the intracellular cAMP level and topical applica-
tion of cAMP antagonist or inhibition of cAMP synthesis
accelerated barrier recovery. The increase of intracellular
cAMP induced calcium influx in the epidermal keratinocytes
and delayed barrier recovery The calcium influx was
blocked by nifedipine and verapamil. These results suggest
that various G protein-linked metabotropic receptors are
involved in skin barrier homeostasis.
Materials and Methods
Animals All experiments were performed on 7 to 10 wk old male
hairless mice (HR-1, Hoshino, Japan). The measurement of skin
barrier function, disruption of the barrier, and application of test
sample were carried out under anesthesia with nembutal. All
Figure 6
The delay of the barrier repair induced
by the application of forskolin was
blocked by pretreatment with nifedi-
pine or verapamil. (A) One hour after tape
stripping; (B) 3 h after tape stripping; (C) 6
h after tape stripping. Two points were
measured on the flank. Number of mea-
sured points, n¼8 (number of animals
was 4 for each measurement).
Figure 7
Forskolin increased the intracellular calcium concentration in the
cultured keratinocytes and the increase was blocked by nifedipine
or verapamil. Vertical axis shows the ratio of relative intensity (340 nm/
380 nm) after treatment to that before treatment. Number of cells
for each measurement was 30. Results of ANOVA test: F¼61,826,
p o 0.0001.
Figure8
Scheme of the signaling process between Gs linked receptors and
voltage-gated calcium channel. Skin barrier disruption might activate
Gs protein linked receptor. It might activate adenyl cyclase and
accelerate synthesis of cAMP. cAMP might open voltage-gated calcium
channel and induce calcium ion flux into keratinocytes. PKA might not
be involved in this cascade. Influx of calcium ion delays barrier
recovery. Thus, inhibition of adenyl cyclase or the antagonist of cAMP
might accelerate barrier recovery as we demonstrated in this study.
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experiments were approved by the Animal Research Committee of
the Shiseido Research Center in accordance with the National
Research Council Guide (National Research Council, 1996).
Reagents cAMPs Rp, antagonist of cAMP (Van Haastered et al,
1984), was purchased from Tocris Cookson Ltd (Bristol, UK).
9-Cyclopentyl adenine, (inhibitor of adenyl cyclase) (Johnson,
1997) was purchased from Sigma (St Louis, Missouri). Forskolin,
which increases cAMP synthesis (Awad et al, 1983), nifedipine, and
verapamil, both of which block voltage-gated calcium channel,
were purchased from WAKO (Osaka, Japan). Human neonatal
keratinocytes were purchased from BioWhittaker Inc. (Walkersville,
Maryland).
Cutaneous barrier function Permeability barrier function was
evaluated by measurement of transepidermal water loss (TEWL)
with an electric moisture analyzer (Meeco, Warrington, Pennsylva-
nia), as described previously (Denda et al, 1998b). For barrier
recovery experiments, the skin on both flanks was treated by
repeated tape stripping or acetone-soaked cotton balls until the
TEWL reached 7 to 10 mg per cm2 per h, as described previously
(Denda et al, 1998b). Immediately after barrier disruption, 100 mL of
an aqueous solution containing each reagent or water alone
(control) was applied to the treated area (2  3 cm2). We applied a
different reagent on each flank. The areas were covered with
plastic membrane (Kure wrap, Kureha Chemical Industry, Tokyo,
Japan) for 15 min for better penetration of reagent and then
uncovered. Two points were measured per flank and four mice
were used to evaluate the effects of each treatment. TEWL was
then measured at the same sites at 1, 3, and 6 h after barrier
disruption. Barrier disruption was done between 07.00 h and 08.00
h and then the barrier recovery rate was evaluated immediately to
avoid the effect of circadian rhythm (Denda and Tsuchiya, 2000).
The barrier recovery results are expressed as percentage of
recovery, because of variations from day to day in the extent of
barrier disruption. In each animal, the percentage of recovery was
calculated by the following formula: (TEWL immediately after
barrier disruption—TEWL at indicated time point)/(TEWL immedi-
ately after barrier disruption—baseline TEWL)  100%.
cAMP evaluation Mice were euthanized by diethylether inhalation
and skin samples were taken from both flanks immediately. The
level of cAMP in skin is easily influenced by a systemic factor
(Saitoh et al, 1980). Thus, we performed an in vitro study. The two
pieces of skin from both flanks were placed, epidermis side
upwards, in phosphate-buffered saline buffer in separate culture
dishes kept at 371C, and one of them was tape stripped four times.
The other piece of skin was not treated. After a 1 h incubation, the
skin was put on a hot plate (601C) for 30 s and then the epidermis
was separated. The epidermis was homogenized in phosphate-
buffered saline and centrifuged to remove large particles. An
aliquot was removed for assay of both cAMP and protein. cAMP in
samples with 0.1 M HCl was quantitated by a immunoassay with a
cAMP enzyme immunoassay (EIA) kit (Sigma) according to the
manufacturer’s instructions.
Light and electron microscopy For the series of histologic
studies, we used animals different from those used in the barrier
kinetics experiment. Flanks were treated with acetone-soaked
cotton ball. One hour later, the animals were euthanized by
inhalation of diethyl ether and skin samples were isolated. We used
three animals for each treatment and four sections were taken from
each sample. Skin samples for fluorescence microscopy were
embedded in OCT compound, sectioned and 4 mM Nile Red (100
mg per mL, 75% glycerol) was applied. Sections were examined
with a microscope (Vanox AHBT3, Olympus) equipped for
epifluorescence at an excitation of 470 to 490 nm and emission
of 520 nm (Denda et al, 1998b). For the observation, at least five
sections were observed to find common features.
The full thickness of skin samples for electron microscopy was
minced into pieces (o0.5 mm3) and fixed in modified Karnovsky’s
fixative overnight. Three mice were used for each treatment. They
were then postfixed in 2% aqueous osmium tetroxide or 0.2%
ruthenium tetroxide as described previously (Denda et al, 1998b).
After fixation, all samples were dehydrated in a graded ethanol
series, and embedded in an Epon-epoxy mixture. Thin sections
were stained with lead citrate and uranyl acetate and viewed by
electron microscopy (Denda et al, 1998b). The area of SC/SG lipid
domain was quantitated from osmium postfixed material. Mea-
surements were made without knowledge of the prior experimental
treatment. The parameter was evaluated from photographs of
randomly selected sections at a constant magnification, using
computer software (NIH image).
Calcium dynamics in keratinocyte culture system Changes in
[Ca2þ ]i in a single cell were measured using fura-2 as described by
Grynkiewicz et al (1985) with minor modifications (Koizumi and
Inoue, 1997). All in vitro cell culture measurements were carried out
using the second passage of human neonatal keratinocytes. First,
we incubated cells in a low calcium medium (0.1 mM calcium,
Defined Keratinocyte SFM, Gibco BRL, Grand Island, New York) for
at least 5 d and used the cells within 10 d. These keratinocytes
showed 80 to 100% confluency. We calibrated the calcium
concentration without cells and found that the parameter was the
absolute value of calcium. The culture medium was replaced with
buffered saline solution containing 150 mM NaCl, 10 mM glucose,
25 mM HEPES, 5 mM KCl, 1.2 mM NaH2PO4, 1.2 mM MgCl2, and
1.8 mM CaCl2; and was adjusted to pH 7.4 with NaOH. Then, after
adding fura-2 acetoxymethylester (Molecular Probes Inc., Eugene,
Oregon) to the final concentration of 5 mM, cells were incubated for
45 min at room temperature (21–231C). The cells were washed in
saline and then incubated for a further 15 min to allow de-
esterification of the loaded fura-2 acetoxymethylester. The cover-
slip was mounted on a fluorescence microscope (IX70, TS
Olympus, Tokyo, Japan) equipped with a 75 W xenon lamp and
band-pass filters of 340 nm and 380 nm wavelengths. Measure-
ments were carried out at room temperature. Imaging data were
recorded with a high-sensitive silicon intensifier target camera
(C4742, Hamamatsu Photonics, Hamamatsu, Japan) using a Ca2þ
analyzing system (AQUA/RATI01, Hamamatsu Photonics, Hama-
matsu, Japan).
Statistics The results are expressed as the mean  SD. Data
were analyzed by ANOVA test and then the difference was evaluated
by Fisher’s protected least significant difference.
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